Terns Pharmaceuticals, Inc. (TERN) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1M | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | -100% | - | - | - | - | - | - | - |
| Cost of Goods Sold | -108K | 0 | 108K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 108K | 0 | -108K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1M | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - | -100% | - | - | - | - | - | - | - |
| Operating Expenses | 27.71M | 27.72M | 27.27M | 27.43M | 25.95M | 24.94M | 25.54M | 25.45M | 24.06M | 33.18M | 21.16M | 24.16M | 16.83M | 17.29M | 14.08M | 13.82M | 14.88M | 11.87M | 10.82M | 13.3M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1487.8% | - | - | - |
| Selling, General & Admin | 8.7M | 7.8M | 7.03M | 8.71M | 7.95M | 9.77M | 7.18M | 6.86M | 6.6M | 18.35M | 7.01M | 7.1M | 6.17M | 5.13M | 5.42M | 5.69M | 5.42M | 4.71M | 4.86M | 4.56M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 541.6% | - | - | - |
| Research & Development | 18.9M | 19.92M | 20.35M | 18.72M | 18M | 15.17M | 18.35M | 18.59M | 17.46M | 14.83M | 14.15M | 17.06M | 10.66M | 12.16M | 8.66M | 8.14M | 9.46M | 7.15M | 5.96M | 8.73M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 946.2% | - | - | - |
| Other Operating Expenses | 108K | 0 | -108K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -27.6M | -27.72M | -27.38M | -27.43M | -25.95M | -24.94M | -25.54M | -25.45M | -24.06M | -33.18M | -21.16M | -24.16M | -16.83M | -17.29M | -14.08M | -13.82M | -13.88M | -11.87M | -10.82M | -13.3M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1387.8% | - | - | - |
| Operating Income Growth % | -6.35% | -11.14% | -7.23% | -7.79% | -7.86% | 24.85% | -20.69% | -5.34% | -42.96% | -91.9% | -50.23% | -74.73% | -21.26% | -45.7% | -30.19% | -3.98% | -58.28% | -35.84% | - | -41.1% |
| EBITDA | -27.89M | -27.7M | -27.27M | -27.26M | -25.73M | -24.73M | -25.3M | -25.21M | -23.99M | -32.96M | -20.94M | -23.93M | -16.59M | -17.04M | -13.81M | -13.55M | -13.76M | -11.76M | -10.7M | -13.12M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1376.4% | - | - | - |
| EBITDA Growth % | -8.36% | -12.01% | -7.82% | -8.12% | -7.29% | 24.97% | -20.8% | -5.33% | -44.54% | -93.44% | -51.59% | -76.68% | -20.57% | -44.89% | -29.12% | -3.22% | -58.9% | -36.19% | - | -40.59% |
| D&A (Non-Cash Add-back) | -289K | 12K | 108K | 169K | 214K | 206K | 240K | 236K | 72K | 222K | 217K | 222K | 233K | 252K | 269K | 278K | 114K | 107K | 119K | 172K |
| EBIT | -34.08M | -24.59M | -24.03M | -27.43M | -25.95M | -24.94M | -25.54M | -25.45M | -24.06M | -33.18M | -21.16M | -24.16M | -16.83M | -17.29M | -14.08M | -13.82M | -13.88M | -11.87M | -10.82M | -13.3M |
| Net Interest Income | 4.46M | 3.14M | 3.35M | 3.64M | 4.14M | 3.09M | 2.88M | 3.18M | 3.33M | 3.48M | 3.4M | 2.69M | 1.33M | 499K | 214K | 69K | 55K | 49K | 55K | 11K |
| Interest Income | 4.46M | 3.14M | 3.35M | 3.64M | 4.14M | 3.09M | 2.88M | 3.18M | 3.33M | 3.48M | 3.4M | 2.69M | 1.33M | 499K | 214K | 69K | 55K | 49K | 55K | 11K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 4.41M | 3.13M | 3.35M | 3.61M | 4.19M | 3.06M | 2.86M | 3.17M | 3.09M | 3.48M | 3.33M | 2.69M | 1.32M | 485K | 160K | 73K | 65K | 53K | 94K | -2K |
| Pretax Income | -23.19M | -24.59M | -24.03M | -23.82M | -21.76M | -21.88M | -22.68M | -22.28M | -20.97M | -29.71M | -17.82M | -21.47M | -15.5M | -16.81M | -13.92M | -13.75M | -13.81M | -11.81M | -10.72M | -13.3M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1381.3% | - | - | - |
| Income Tax | 383K | 46K | 64K | 88K | 40K | 62K | 61K | 97K | 49K | 58K | 72K | 60K | 318K | 13K | 6K | 21K | 435K | 20K | 14K | 39K |
| Effective Tax Rate % | -1.65% | -0.19% | -0.27% | -0.37% | -0.18% | -0.28% | -0.27% | -0.44% | -0.23% | -0.2% | -0.4% | -0.28% | -2.05% | -0.08% | -0.04% | -0.15% | -3.15% | -0.17% | -0.13% | -0.29% |
| Net Income | -23.57M | -24.64M | -24.09M | -23.91M | -21.8M | -21.95M | -22.74M | -22.37M | -21.02M | -29.77M | -17.9M | -21.53M | -15.82M | -16.82M | -13.93M | -13.77M | -14.25M | -11.84M | -10.74M | -13.34M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1424.8% | - | - | - |
| Net Income Growth % | -8.13% | -12.26% | -5.97% | -6.86% | -3.71% | 26.28% | -27.05% | -3.93% | -32.85% | -76.97% | -28.47% | -56.31% | -11.05% | -42.12% | -29.73% | -3.27% | -1945.6% | -3.5% | - | -48.17% |
| Net Income (Continuing) | -23.57M | -24.64M | -24.09M | -23.91M | -21.8M | -21.95M | -22.74M | -22.37M | -21.02M | -29.77M | -17.9M | -21.53M | -15.82M | -16.82M | -13.93M | -13.77M | -14.25M | -11.84M | -10.74M | -13.34M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.24 | -0.27 | -0.26 | -0.26 | -0.24 | -0.28 | -0.31 | -0.30 | -0.29 | -0.42 | -0.25 | -0.31 | -0.29 | -0.44 | -0.55 | -0.55 | -0.56 | -0.47 | -0.43 | -0.53 |
| EPS Growth % | 0% | 3.57% | 16.13% | 13.33% | 17.24% | 33.33% | -24% | 3.23% | 0% | 4.55% | 54.55% | 43.64% | 48.21% | 6.38% | -27.91% | -3.77% | -1924.1% | 2.08% | - | -39.47% |
| EPS (Basic) | -0.24 | -0.27 | -0.26 | -0.26 | -0.24 | -0.28 | -0.31 | -0.30 | -0.29 | -0.42 | -0.25 | -0.31 | -0.29 | -0.44 | -0.55 | -0.55 | -0.56 | -0.47 | -0.43 | -0.53 |
| Diluted Shares Outstanding | 93.17M | 91.7M | 91.58M | 91.47M | 91.24M | 77.82M | 74.46M | 74.4M | 72.33M | 71.53M | 71.36M | 69.78M | 54.7M | 38.51M | 25.3M | 25.27M | 25.27M | 25.15M | 25.11M | 25.12M |
| Basic Shares Outstanding | 93.17M | 91.7M | 91.58M | 91.47M | 91.24M | 77.82M | 74.46M | 74.4M | 72.33M | 71.53M | 71.36M | 69.78M | 54.7M | 38.51M | 25.3M | 25.27M | 25.27M | 25.15M | 25.11M | 25.12M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |